A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Public ClinicalTrials.gov record NCT07142356. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this clinical trial is to learn if the drug RT-001 works to reduce high blood pressure (hypertension) in adults. It will also learn about the safety of RTN-001. The main questions it aims to answer are: Does RTN-001 lower blood pressure in patients who have uncontrolled hypertension? What medical problems do participants have when taking RTN-001? Researchers will compare RTN-001 to a placebo (a look-alike substance that contains no drug) to see if RTN-001 works to treat uncontrolled hypertension. Participants will: Take RTN-001 or a placebo every day for 12 weeks Visit the clinic about once every 2 weeks for checkups and tests Keep a diary of their symptoms and all medications that they take including RTN-001
Study identification
- NCT ID
- NCT07142356
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 280 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 30, 2025
- Primary completion
- Sep 30, 2026
- Completion
- Apr 30, 2027
- Last update posted
- Jun 28, 2026
2025 – 2027
United States locations
- U.S. sites
- 22
- U.S. states
- 12
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retension Clinical Site | Tucson | Arizona | 85715 | Recruiting |
| Retension Clinical Site | San Jose | California | 95128 | Recruiting |
| Retension Clinical Site | West Hills | California | 91307 | Recruiting |
| Retension Clinical Site | Waterbury | Connecticut | 06708 | Recruiting |
| Retension Clinical Site | Orlando | Florida | 32801 | Recruiting |
| Retension Clinical Site | Port Orange | Florida | 32127 | Recruiting |
| Retension Clinical Site | Tampa | Florida | 33606 | Recruiting |
| Retension Clinical Site | Lawrenceville | Georgia | 30044 | Recruiting |
| Retension Clinical Site | Peachtree Corners | Georgia | 30092 | Recruiting |
| Retension Clincial Site | Boston | Massachusetts | 02131 | Recruiting |
| Retension Clinical Site | Las Vegas | Nevada | 89109 | Recruiting |
| Retension Clinical Site | Las Vegas | Nevada | 89121 | Recruiting |
| Retension Clinical Site | Asheboro | North Carolina | 27203 | Recruiting |
| Retension Clinical Site | Charlotte | North Carolina | 28210 | Recruiting |
| Retension Clinical Site | Monroe | North Carolina | 28112 | Recruiting |
| Retension Clinical Site | Cincinnati | Ohio | 45245 | Recruiting |
| Retension Clinical Site | Charleston | South Carolina | 29407 | Recruiting |
| Retension Clinical Site | Bellaire | Texas | 77401 | Recruiting |
| Retension Clinical Site | Dallas | Texas | 75230 | Recruiting |
| Retension Clincal Site | Plano | Texas | 75024 | Recruiting |
| Retension Clinical Site | San Antonio | Texas | 78215 | Recruiting |
| Retension Clinical Site | Vienna | Virginia | 22182 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07142356, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 28, 2026 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07142356 live on ClinicalTrials.gov.